Patents by Inventor Jasper Rupert Clube

Jasper Rupert Clube has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9034332
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: May 19, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9034331
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: May 19, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 9023359
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: May 5, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Method of treating rheumatoid arthritis using antibody to IL6R
    Patent number: 9017678
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: April 28, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 8999341
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: April 7, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting human NAV1.7 variants for treatment of pain
    Patent number: 8992927
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: March 31, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Method of treating atopic dermatitis or asthma using antibody to IL4RA
    Patent number: 8986691
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: March 24, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting human nav1.7 variants for treatment of pain
    Patent number: 8986694
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: March 24, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Method of treating atopic dermatitis or asthma using antibody to IL4RA
    Patent number: 8980273
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: March 17, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 8951523
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: February 10, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Method of treating rheumatoid arthritis using antibody to IL6R
    Patent number: 8945560
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: February 3, 2015
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 8883157
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: November 11, 2014
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube